FDA Investigator Joslyn K Brunelle, PhD
Joslyn K Brunelle, PhD has inspections in 1 countries as of 23 Jun 2023. Joslyn K Brunelle, PhD has collaborated with a combinined 1508 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
23 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Andrew W Harmon,
Angel K Sandhu,
Anh M Lac,
Ashar P Parikh,
Bo Chi, PhD,
Brian A Roelofs,
Candace Y Gomez Broughton,
Carl Lee,
Carolyn A Renshaw,
CDR Rochelle B Young, RPh, MSA,
Cristina Ausin Moreno, PhD,
Cristina Ausin Moreoo, PhD,
Diane L Raccasi,
Dilip Devineni, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Eboni S Funderburk,
Edwin Jao,
Eileen A Liu,
Emilie E Kahn,
Emmanuel Adu Gyamfi,
Eric M Mueller, PharmD,
Esther C Broner, PhD,
Henry K Lau,
Hung H Do, MS,
Hyung Yul Lee,
Ian L Mcwilliams,
James A Lane,
Jeffrey D Meng,
Jeffrey M Watson,
Jolanna A Norton,
Jon P Antoniou,
Joseph A Piechocki,
Kalavati Suvarna, PhD,
Kevin P Foley,
Kula N Jha,
Lance M De Souza, MBA,
Laura Fontan, MS,
Laurie Graham,
LCDR Sean Byrd,
Logan T Williams,
Maria Cruz Fisher,
Maria I Cruz Fisher,
Massod Rahimi, PhD,
Meisha R Sampson,
Meisha Waters,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele Perry Williams,
Muna Algharibeh,
Muna Alghribeh,
Nicholas L Paulin,
Paula A Trost,
Prabhu P Raju,
Rabia Ballica, PhD,
Raymond T Oji,
Richard Ledwidge (nmi), PhD,
Robert Barbosa,
Robert J Ham,
Robert M Barbosa,
Sandra A Boyd,
Sargum C Sood,
Scott R Nichols, PhD,
Sean R Bryd,
Sherri J Jackson,
Sidney B Priesmeyer,
Sneha S Patel,
Steven D Kehoe,
Tara L Greene,
Tara L King,
Thomas J Arista,
Thomas R Withers,
Timothy J Schmidt,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Vaishali J Patel,
Warren J Lopicka,
Wayne E Seifert,
William V Millar,
Yanming An, PhD,
Ying Xin Fan, PhD,
Yiyue Zhang (nmi), PhD,
Zhang Zhao, PhD
Joslyn K Brunelle, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2017 | EIR | BioMarin Pharmaceutical Inc. - EIR, 2017-12-14 |
| December, 2017 | FDA 483 | BioMarin Pharmaceutical Inc. - Form 483, 2017-12-14 |
| October, 2018 | FDA 483 | Patheon Biologics LLC - Form 483, 2018-10-09 |
| October, 2013 | EIR | Catalent Indiana, LLC - EIR, 2013-10-25 |
| October, 2013 | FDA 483 | Catalent Indiana, LLC - Form 483, 2013-10-25 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more